Clinical Trial Update: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating testosterone replacement therapy for its effect on major adverse cardiovascular events and efficacy in hypogonadal men; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hypogonadism

Drugs mentioned

• Testosterone replacement therapy (testosterone)

Snippet

Sponsor: AbbVie | Conditions: Hypogonadism, Cardiovascular Diseases | Phase 4 | Status: COMPLETED | Results posted: 2024-03-13